On Demand 2018 Thursday Program
The Thursday Program contains the morning and afternoon sessions:
- Biologic Therapies in Your Practice
- Phenotypes/Endotypes for Biologics
- Targets in Use of Biologics
- Asthma and Upper Airway Diseases
- Dermatologic Diseases (using biologics)
- How to Choose, Use and Bill
- Drug Allergy and the Allergist: Staying Relevant
- Antibiotic Desensitization
- Antiobiotic Stewardship
- The Allergist in the Community Hospital
- How Academic Centers are Reacting
- Drug Allergy Coding and Billing
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 6 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
Upon completion of this session, participants should be able to:
- Outline an approach to the use of biologics for allergic diseases.
- Describe clinical criteria for severe asthma and allergic diseases and identify known phenotypes and endotypes that can inform treatment selection.
- Utilize available information to guide personalized treatment of asthma and allergic diseases and describe the most recent clinical data on new and emerging therapies.
- Utilize available information to guide personalized treatment of atopic dermatitis and chronic urticaria and describe the most recent clinical data on new and emerging therapies.
- Develop an understanding on how to effectively choose, use and bill for biologics.
- Summarize and plan how to utilize antibiotic desensitization.
- Recognize how antibiotic stewardship works and identify the allergist’s role.
- Give examples of how the allergist can assist in various settings with drug allergies.
- Distinguish the different coding and billing options available for drug allergy evaluation and testing.
Larry Borish, MD, FACAAI
Tara Carr, MD
Thomas Casale, MD
Mariana Castells, MD, PhD, FACAAI
Jonathan Corren, MD
Emma Guttman-Yassky, MD
David Khan, MD, FACAAI
David Lang, MD, FACAAI
Bobby Lanier, MD
Eric Macy, MD
Santiago Martinez, MD, FACAAI
John Oppenheimer, MD, FACAAI
Stephen Peters, MD, PhD
Jonathan Silverberg, MD, PhD, MPH
David Spach, MD
James L. Sublett, MD, FACAAI
Michael Weiss, MD
Cherie Zachary, MD, FACAAI
- 6.00 AMA PRA Category 1 Credit™
- 6.00 Attendance